Navigation Links
TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
Date:9/10/2007

on between patients and their physicians about clinical trials provides a wonderful tool to help link patients with the right trial for them. As a result, we'll accelerate our understanding of cancer."

Updating Trial Locations in Real Time

Real-time updates are a distinguishing feature of TrialCheck that will also benefit users. In 2006, the Coalition introduced a technology enhancement that imports location information upon receipt for Cooperative Group trials. Participating oncology practices and hospitals appear in a trial record in real time as they are federally approved to participate in that study; conversely, locations are removed in real time from the database record when the study is closed or no longer available at that site. With outdated location information a common problem among trial databases, real-time updates are a popular feature among TrialCheck users. While real-time updates currently apply only to Cooperative Group studies, the proprietary informatics platform developed for real-time updates is a possible model for the Coalition to replicate with other types of studies in the future (pharmaceutical and biotech companies, cancer centers offering their studies in multiple locations, and other government-sponsored studies).

Tracking Clinical Trial Trends

An innovative TrialCheck feature, TrialTracker, will capture a vivid picture of patients' clinical trial experiences, determining whether they took steps and ultimately were enrolled into a trial. For the first time, the American Cancer Society can gain an expansive view of cancer clinical trial activity generated from its services and patient support initiatives, tracking the experiences of patients individually and collectively. In addition to activity around the thousands of nationally registered cancer clinical trials open and seeking patients in the United States, the TrialTracker service will provide comprehensive reporting on demographics and insights into patient b
'/>"/>

SOURCE Coalition of Cancer Cooperative Groups
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Celsion Corporation (the "Company") (NASDAQ: CLSN ... institutional investors to purchase an aggregate of approximately $15 ... registered direct offering, led by a dedicated health care ... agreements with these investors pursuant to which the Company ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
(Date:4/23/2014)... predict which patients might suffer potentially fatal side-effects from ... assesses brain scans using pattern recognition software similar to ... been developed by researchers at Imperial College London. Results ... which used the software are published in the journal ... 15 million people each year worldwide. Ischemic strokes are ...
(Date:4/23/2014)... and vegetables are often displayed in the popular ... also plenty of high-sugar foods. A new study ... is portrayed in children,s TV programmes as well ... dietary habits and weight status. , Steingerdur Olafsdottir,s ... in the popular Swedish children,s TV show Bolibompa. ...
(Date:4/23/2014)... and physicians concerned about an increase in adolescents, marijuana ... a sigh of relief. According to a new study ... of data from states with and without medical marijuana ... use among adolescents. The study is published online in ... Health . , "Any time a state considers ...
(Date:4/23/2014)... have shown that proliferation of endogenous neural precursor ... neurons and axons. From the perspective of neural ... Yat-sen University in China observed the effects of ... cell proliferation and expression of basic fibroblast growth ... brain on the infarct side. The researchers found ...
(Date:4/22/2014)... FDA-approved device has been shown to reduce seizures in ... percent. When coupled with an innovative electrode placement planning ... the complete elimination of seizures in nearly half of ... trials. , That,s good news for a large portion ... with epilepsy whose seizures can,t be controlled with medications ...
Breaking Medicine News(10 mins):Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2
... brief immobilization than with bandage or boot, study finds, , , ... sprains recover faster with a short period of immobilization in ... use of either a tubular compression bandage or a Bledsoe ... with receiving one of the four types of joint support, ...
... intended to help reduce cardiovascular disease in womenWASHINGTON, ... could force some women to make tough choices ... Murkowski (R-AK) and Congresswomen Lois Capps (D-CA) and ... would expand access to screening and lifestyle counseling ...
... 12 The Disabled American Veterans today applauds ... timely and predictable funding for veterans health care ... to the budget process."The Veterans Health Care Budget ... government more efficient, transparent and accountable. These are ...
... S.C., Feb. 12 Charleston Laboratories, Inc, an,emerging ... vomiting (OINV) in opioid pharmaceuticals, announced preliminary,findings from ... Questionnaire,or OSQ, which will be used in Charleston,s ... pilot methodology study was designed to test the ...
... Authentidate Holding Corp. (Nasdaq: ADAT ), a ... management services, today announced financial results for the fiscal ... President of Authentidate, stated, "Revenue growth slowed during the ... impacted our results. Although total revenues were down ...
... be the only thing that can be using to enhance eyelashes. ... was developed through years of research by Allergan, a pharmaceutical leader ... , ... Beverly Hills, CA (PRWEB) February 12, 2009 ...
Cached Medicine News:Health News:Casting Seems Best for Severe Ankle Sprains 2Health News:Stabenow, Murkowski, Capps and Bono Mack Reintroduce HEART for Women Act 2Health News:Stabenow, Murkowski, Capps and Bono Mack Reintroduce HEART for Women Act 3Health News:Stabenow, Murkowski, Capps and Bono Mack Reintroduce HEART for Women Act 4Health News:Veterans Health Care Funding Reform Bill Promises Transparency, Accountability 2Health News:Veterans Health Care Funding Reform Bill Promises Transparency, Accountability 3Health News:Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire 2Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 2Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 3Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 4Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 5Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 6Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 7Health News:Authentidate Holding Corp. Reports Fiscal 2009 Second Quarter Results 8Health News:Make Lashes Longer, Thicker, and Darker with Latisse™ 2Health News:Make Lashes Longer, Thicker, and Darker with Latisse™ 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: